AXA raised its position in shares of Stericycle Inc (NASDAQ:SRCL) by 1,090.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 124,875 shares of the business services provider’s stock after purchasing an additional 114,386 shares during the period. AXA owned about 0.15% of Stericycle worth $8,943,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Schwab Charles Investment Management Inc. raised its position in shares of Stericycle by 8.9% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 463,513 shares of the business services provider’s stock worth $35,376,000 after acquiring an additional 37,927 shares in the last quarter. Arizona State Retirement System increased its position in Stericycle by 0.5% during the 2nd quarter. Arizona State Retirement System now owns 21,190 shares of the business services provider’s stock valued at $1,617,000 after buying an additional 100 shares in the last quarter. Advisors Asset Management Inc. increased its position in Stericycle by 3.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 10,716 shares of the business services provider’s stock valued at $818,000 after buying an additional 333 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its position in Stericycle by 46.3% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 37,917 shares of the business services provider’s stock valued at $2,894,000 after buying an additional 12,000 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Stericycle by 84.3% during the 2nd quarter. SG Americas Securities LLC now owns 26,625 shares of the business services provider’s stock valued at $2,032,000 after buying an additional 12,178 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.
In other news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $67.43, for a total transaction of $1,331,944.79. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last 90 days, insiders have sold 79,012 shares of company stock valued at $5,240,668. Company insiders own 3.50% of the company’s stock.
Several analysts have weighed in on the company. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Barrington Research dropped their price target on Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a research note on Friday, November 10th. Stifel Nicolaus restated a “buy” rating and issued a $85.00 target price on shares of Stericycle in a research note on Thursday, December 28th. Jefferies Group set a $83.00 target price on Stericycle and gave the stock a “buy” rating in a research note on Wednesday, December 13th. Finally, BidaskClub upgraded Stericycle from a “strong sell” rating to a “sell” rating in a research report on Saturday, December 2nd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $74.45.
Shares of Stericycle Inc (NASDAQ SRCL) traded up $0.02 during trading on Friday, reaching $71.60. The company had a trading volume of 857,516 shares, compared to its average volume of 554,183. The stock has a market capitalization of $6,110.99, a price-to-earnings ratio of -125.61, a price-to-earnings-growth ratio of 1.74 and a beta of 0.16. Stericycle Inc has a 52 week low of $61.25 and a 52 week high of $88.00. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.04). Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The business had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. During the same quarter in the previous year, the company posted $1.24 earnings per share. The company’s revenue was down .8% on a year-over-year basis. equities research analysts predict that Stericycle Inc will post 4.49 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/01/13/stericycle-inc-srcl-stake-increased-by-axa.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.